Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer

Supporting evidence

• Review decision

• Review decision – December 2019

• Review proposal paper (PDF 460 KB)

  Published:

  18 December 2019

• Stakeholder list (PDF 164 KB)

  Published:

  18 December 2019

• Evaluation report

• Final appraisal determination committee papers (PDF 968 KB)

  Published:

  02 June 2015

• Appraisal consultation committee papers (PDF 7.37 MB)

  Published:

  22 December 2014